Cargando…

Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option?

Detalles Bibliográficos
Autores principales:	Megna, Matteo, Potestio, Luca, Di Caprio, Nicola, Tajani, Andrea, Fabbrocini, Gabriella, Annunziata, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285779/ https://www.ncbi.nlm.nih.gov/pubmed/35261135 http://dx.doi.org/10.1111/dth.15423

Ejemplares similares

Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report
por: Battista, Teresa, et al.
Publicado: (2022)

Dermoscopy of Acrodermatitis Continua of Hallopeau
por: Mittal, Setu, et al.
Publicado: (2022)

Acrodermatitis continua of Hallopeau: clinical perspectives
por: Smith, Mary Patricia, et al.
Publicado: (2019)

Pustular Psoriasis of Pregnancy with Acrodermatitis Continua of Hallopeau
por: Shah, Akanksha, et al.
Publicado: (2016)

Acrodermatitis Continua of Hallopeau: A Diagnostic Challenge
por: Mitra, Debdeep, et al.
Publicado: (2022)

Acrodermatitis Continua of Hallopeau Evolving into Generalised Pustular Psoriasis
por: Ranugha, Poovanur SS, et al.
Publicado: (2013)

Clinico-Pathological and Dermoscopic Features in Acrodermatitis Continua of Hallopeau
por: Taneja, Gargi, et al.
Publicado: (2021)

Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis
por: Xia, Rui Yuan, et al.
Publicado: (2023)

Acrodermatitis continua of Hallopeau and geographic tongue are variants of pustular psoriasis
por: Sadlier, Muriel
Publicado: (2018)

A Case of Acrodermatitis Continua of Hallopeau Following Chronic Pustular Cheilitis
por: Arisi, Mariachiara, et al.
Publicado: (2016)

Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report
por: Crowley, Erika L, et al.
Publicado: (2019)

Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report
por: Cirone, Katrina D, et al.
Publicado: (2023)

Successful treatment of acrodermatitis continua of Hallopeau with tildrakizumab: A case report
por: Nguyen, Alex, et al.
Publicado: (2023)

Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature
por: Galluzzo, Marco, et al.
Publicado: (2019)

Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau
por: Smirnova, LM, et al.
Publicado: (2019)

Successful Treatment of Acrodermatitis Continua of Hallopeau with an Anti-IL-17A Agent
por: Inoue, Sae, et al.
Publicado: (2021)

Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Treatment and molecular profiling of acrodermatitis continua of Hallopeau during pregnancy using targeted therapy
por: Al-Khawaga, Sara, et al.
Publicado: (2021)

Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review
por: Shi, Liping, et al.
Publicado: (2023)

Acrodermatitis Continua of Hallopeau with Bone Resorption in an 8-Year-Old Patient: A Case Report
por: Alorainy, May, et al.
Publicado: (2017)

Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort
por: Assan, F., et al.
Publicado: (2022)

Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
por: Megna, Matteo, et al.
Publicado: (2021)

Speckled variance optical coherence tomography for the assessment of nail involvement in acrodermatitis continua of Hallopeau: A case study
por: Conti, Andrea, et al.
Publicado: (2016)

Acrodermatitis of Hallopeau and erosive oral mucositis successfully treated with secukinumab
por: Baron, Jennifer A.
Publicado: (2017)

Letter to the editor regarding the article “Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID‐19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610.”
por: Potestio, Luca, et al.
Publicado: (2022)

A case of erythrodermic psoriasis successfully treated with apremilast
por: Megna, Matteo, et al.
Publicado: (2021)

Teledermatology: A useful tool also after COVID‐19 era?
por: Megna, Matteo, et al.
Publicado: (2022)

Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID‐19: A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin
por: Samotij, Dominik, et al.
Publicado: (2021)

A rare case of Acrodermatitis continua of Hallopeau successfully treated with topical calcipotriol/betamethasone dipropionate ointment associated with Jaccaud’s arthropathy: A case report
por: Ngo, Jennifer Lavina, et al.
Publicado: (2022)

Letter to the editor regarding article “Yalici‐Armagan B, Tabak GH, Dogan‐Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID‐19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1–5”
por: Potestio, Luca, et al.
Publicado: (2021)

Case Report: Paradoxical acrodermatitis of Hallopeau-like eruption following anti-IL-17 therapy
por: Tadiotto Cicogna, Giulia, et al.
Publicado: (2019)

Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study
por: Megna, Matteo, et al.
Publicado: (2022)

Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis
por: Potestio, Luca, et al.
Publicado: (2023)

Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation
por: Megna, Matteo, et al.
Publicado: (2022)

A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab
por: Megna, Matteo, et al.
Publicado: (2022)

Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
por: Potestio, Luca, et al.
Publicado: (2023)

Generalized pustular psoriasis rapidly and successfully treated with ixekizumab in a Caucasian patient
por: Megna, Matteo, et al.
Publicado: (2022)

Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Risankizumab treatment in psoriasis patients who failed anti‐IL17: A 52‐week real‐life study
por: Megna, Matteo, et al.
Publicado: (2022)

Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single‐center retrospective study in a real‐life setting
por: Megna, Matteo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hdaojh672ud3tvvd86kg2o7fp2